no image available Dickens & Co. "Breaching the Barrier: Bortezomib's Groundbreaking Efforts in Battling Relentless Acute Leukemias" "Unveiling the Promising Phase I Study Results of Bortezomib in Intractable Cases" Price: 33.00€